299 related articles for article (PubMed ID: 28923207)
1. Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.
Barwe SP; Quagliano A; Gopalakrishnapillai A
Semin Oncol; 2017 Apr; 44(2):101-112. PubMed ID: 28923207
[TBL] [Abstract][Full Text] [Related]
2. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
[TBL] [Abstract][Full Text] [Related]
3. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
4. [Research Progress on Drug-resistance of Acute Lymphoblastic Leukemia--Review].
Ma JJ; Chen Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):261-5. PubMed ID: 26913433
[TBL] [Abstract][Full Text] [Related]
5. Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche.
Ma C; Witkowski MT; Harris J; Dolgalev I; Sreeram S; Qian W; Tong J; Chen X; Aifantis I; Chen W
Sci Adv; 2020 Oct; 6(44):. PubMed ID: 33127669
[TBL] [Abstract][Full Text] [Related]
6. Targeting chemokines for acute lymphoblastic leukemia therapy.
Hong Z; Wei Z; Xie T; Fu L; Sun J; Zhou F; Jamal M; Zhang Q; Shao L
J Hematol Oncol; 2021 Mar; 14(1):48. PubMed ID: 33743810
[TBL] [Abstract][Full Text] [Related]
7. Notch signaling as a therapeutic target for acute lymphoblastic leukemia.
Bellavia D; Palermo R; Felli MP; Screpanti I; Checquolo S
Expert Opin Ther Targets; 2018 Apr; 22(4):331-342. PubMed ID: 29527929
[TBL] [Abstract][Full Text] [Related]
8. Tetraspanins set the stage for bone marrow microenvironment-induced chemoprotection in hematologic malignancies.
Quagliano A; Gopalakrishnapillai A; Barwe SP
Blood Adv; 2023 Aug; 7(16):4403-4413. PubMed ID: 37561544
[TBL] [Abstract][Full Text] [Related]
9. Microenvironmental cues for T-cell acute lymphoblastic leukemia development.
Passaro D; Quang CT; Ghysdael J
Immunol Rev; 2016 May; 271(1):156-72. PubMed ID: 27088913
[TBL] [Abstract][Full Text] [Related]
10. Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.
Uy GL; Hsu YM; Schmidt AP; Stock W; Fletcher TR; Trinkaus KM; Westervelt P; DiPersio JF; Link DC
Leuk Res; 2015 Dec; 39(12):1437-42. PubMed ID: 26467815
[TBL] [Abstract][Full Text] [Related]
11. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T
Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259
[TBL] [Abstract][Full Text] [Related]
13. CD81 knockout promotes chemosensitivity and disrupts in vivo homing and engraftment in acute lymphoblastic leukemia.
Quagliano A; Gopalakrishnapillai A; Kolb EA; Barwe SP
Blood Adv; 2020 Sep; 4(18):4393-4405. PubMed ID: 32926125
[TBL] [Abstract][Full Text] [Related]
14. Towards an understanding of the biology and targeted treatment of paediatric relapsed acute lymphoblastic leukaemia.
Irving JA
Br J Haematol; 2016 Mar; 172(5):655-66. PubMed ID: 26568036
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.
Barrett AJ; Horowitz MM; Pollock BH; Zhang MJ; Bortin MM; Buchanan GR; Camitta BM; Ochs J; Graham-Pole J; Rowlings PA
N Engl J Med; 1994 Nov; 331(19):1253-8. PubMed ID: 7935682
[TBL] [Abstract][Full Text] [Related]
16. Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study.
Koh KN; Im HJ; Kim H; Kang HJ; Park KD; Shin HY; Ahn HS; Lee JW; Yoo KH; Sung KW; Koo HH; Lim YT; Park JE; Park BK; Park HJ; Seo JJ
J Korean Med Sci; 2017 Apr; 32(4):642-649. PubMed ID: 28244291
[TBL] [Abstract][Full Text] [Related]
17. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study .
Ritchey AK; Pollock BH; Lauer SJ; Andejeski Y; Barredo J; Buchanan GR
J Clin Oncol; 1999 Dec; 17(12):3745-52. PubMed ID: 10577846
[TBL] [Abstract][Full Text] [Related]
18. Adhesion of precursor-B acute lymphoblastic leukaemia cells to bone marrow stromal proteins.
Makrynikola V; Bradstock KF
Leukemia; 1993 Jan; 7(1):86-92. PubMed ID: 8418384
[TBL] [Abstract][Full Text] [Related]
19. The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic Leukemia.
Chiarini F; Paganelli F; Martelli AM; Evangelisti C
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046053
[TBL] [Abstract][Full Text] [Related]
20. ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
Henze G; v Stackelberg A; Eckert C
Klin Padiatr; 2013 May; 225 Suppl 1():S73-8. PubMed ID: 23700062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
